Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDPSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.23.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DY.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LE.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EG.5.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LE.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDQSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LR.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KR.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.41.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.52SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.58.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used